Download full-text PDF

Source
http://dx.doi.org/10.1016/0140-6736(90)90707-cDOI Listing

Publication Analysis

Top Keywords

predominance hiv-1
4
hiv-1 serotype
4
serotype distinct
4
distinct lav-1/htlv-iiib
4
predominance
1
serotype
1
distinct
1
lav-1/htlv-iiib
1

Similar Publications

Introduction: The main obstacle to achieving an HIV-1 cure is the proviral reservoir. To promote equity in HIV cure strategies, it is crucial to study the viral reservoir of the predominant HIV-1 subtype C in both women and men. Therefore, we investigated the dynamics of the (intact) viral reservoir in relation to plasma viral load (VL), CD4 T cell count, and immune activation before and during 96 weeks of successful antiretroviral therapy (ART).

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on the envelope glycoprotein (Env) of HIV-1, which is essential for the virus's ability to infect host cells and is a key target for vaccines and therapies.
  • Researchers analyzed the genetic characteristics of the Env gene in 145 newly diagnosed HIV-1 patients in Baoding City, successfully sequencing 142 samples and predicting coreceptor usage.
  • Results indicated that 50% of the patients were infected with CCR5-tropic viruses, and specific subtypes showed trends in coreceptor preferences and similarities in the V3 loop's net charges, enhancing insights for vaccine and treatment development.
View Article and Find Full Text PDF

Background: The rapid establishment and persistence of latent HIV-1 reservoirs is one of the main obstacles towards an HIV cure. While antiretroviral therapy supresses viral replication, it does not eradicate the latent reservoir of HIV-1-infected cells. Recent evidence suggests that the human microbiome, particularly the gut microbiome, may have the potential to modulate the HIV-1 reservoir.

View Article and Find Full Text PDF
Article Synopsis
  • * There was an increase in the coverage of HIV testing and antiretroviral therapy, with 81% of patients achieving a suppressed viral load by 2023.
  • * Demographic analysis showed that most new HIV cases were among men, with fewer cases from injection drug use and an increase in heterosexual transmission; the median age of patients also rose, revealing significant differences in CD4 counts based on gender and infection route.
View Article and Find Full Text PDF

Human immunodeficiency virus (HIV) continues to be a global health challenge, with over 38 million people infected by the end of 2022. HIV-1, the predominant strain, primarily targets and depletes CD4+ T cells, leading to immunodeficiency and subsequent vulnerability to opportunistic infections. Despite the progress made in antiretroviral therapy (ART), drug resistance and treatment-related toxicity necessitate novel therapeutic strategies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!